Illinois CancerCare - Galesburg — Galesburg, Illinois

Illinois CancerCare - Galesburg is a clinical research site located in Galesburg, Illinois, United States 61401.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Illinois CancerCare - Galesburg has participated in 38 clinical trials with 3 currently active.

Therapeutic areas: Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain.

Sponsors: Alliance for Clinical Trials in Oncology, Seagen, a wholly owned subsidiary of Pfizer, NSABP Foundation Inc.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Illinois CancerCare - Galesburg?

Illinois CancerCare - Galesburg has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Illinois CancerCare - Galesburg conducted?

Illinois CancerCare - Galesburg has 38 clinical trials on record, with 3 currently active. Their work covers Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain.

Is Illinois CancerCare - Galesburg accredited by Crixeo Health?

Yes — Illinois CancerCare - Galesburg holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Illinois CancerCare - Galesburg?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.